The Global Oligonucleotide Synthesis Market Growth Accelerated By Emergence Of New Applications

 
Oligonucleotide Synthesis Market

Oligonucleotides are short sequences of nucleic acid polymers used as probes and primers in DNA sequencing, DNA microarrays, polymerase chain reaction (PCR), oligonucleotide synthesis and hybridization assays. The oligonucleotide synthesis market is driven by the increasing demand for custom oligonucleotides for research and molecular diagnostics. Custom oligonucleotides facilitate disease diagnostics, personalized medicine and genomic analysis.

The global oligonucleotide synthesis market is estimated to be valued at US$ 3,962.67 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The emergence of new applications of oligonucleotides such as therapeutics, antisense oligonucleotides, small interfering RNA (siRNA) and micro RNA (miRNA) have propelled market growth. Antisense oligonucleotides inhibit protein expression by binding to complementary messenger RNA sequences and inhibiting translation. siRNA are used to turn off specific genes for research and potentially therapeutic purposes. Both offer promising alternatives to small molecule drugs and biologics with improved targeting and fewer side effects. Advancements in oligonucleotide synthesis technologies such as phosphoramidite chemistry have enabled mass production of oligonucleotides at reduced cost, further supporting market expansion.

Segment Analysis

The global oligonucleotide synthesis market is dominated by DNA oligonucleotides. DNA oligonucleotides find widespread application in PCR, sequencing, gene synthesis and molecular diagnostics. DNA oligonucleotides are short single stranded DNA polymers that are synthesized in the laboratory and have applications in various life science disciplines including biotechnology research, molecular and cellular biology, genomic and proteomic analysis.

Key Takeaways

The Global Oligonucleotide Synthesis Market Size  is expected to witness high growth over the forecast period of 2023 to 2030. The global oligonucleotide synthesis market is estimated to be valued at US$ 3962.67 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.

North America currently dominates the oligonucleotide synthesis market. Increased funding for research activities from government organizations along with presence of leading oligonucleotide synthesis companies in the region has made North America the largest market. The Asia Pacific region is expected to witness the fastest growth owing to increasing investments by key players, rising awareness about personalized medicine and growing life science research activities in countries such as China and India.

Key players operating in the oligonucleotide synthesis market are Thermo Fisher Scientific, Sigma-Aldrich Corporation, GE Healthcare, Integrated DNA Technologies, Inc., TriLink Biotechnologies€TM, Inc, BioAutomation Corporation, Twist Bioscience, Shanghai SynTheAll Pharmaceutical Co., CUSABIO Technology LLC, Synbio Technologies, GENEWIZ, Eurofins Scientific, Agilent Technologies, Kaneka Eurogentec S.A., and LGC, Biosearch Technologies. These companies continuously focus on new product launches and expansion of their existing product portfolios to strengthen their positions in the global market.

Get more insights on this topic:

https://www.marketwebjournal.com/oligonucleotide-synthesis-market-trends-size-and-share-analysis/

 

Comments

Popular posts from this blog

Eyewear Market Is Estimated To Witness High Growth Owing To the Growing Demand for Prescription Eyewear

The Mobile Computed Tomography Is The Fastest Growing Segment Fueling The Growth Of Computed Tomography Market

The Electronic Warfare Market Will Grow At Highest Pace Owing To Rising Adoption Of Advanced Electronic Warfare Systems In Defense Sector